Anthelmintic resistance is reported in equine nematodes with increasing frequency in recent
years, and no new anthelmintic classes have been introduced during the past 40 years. This …

Macrocyclic lactone (ML) anthelmintics are the most important class of anthelmintics
because of our high dependence on them for the control of nematode parasites and some …

Background The morbidity and socioeconomic effects of onchocerciasis, a parasitic disease
that is primarily endemic in sub-Saharan Africa, have motivated large morbidity and …

Introduction Moxidectin is a milbemycin endectocide recently approved for the treatment of
human onchocerciasis. Onchocerciasis, earmarked for elimination of transmission, is a …

Approximately 250 million people have been using ivermectin (IVM) annually to combat
many parasitic diseases including filariasis, onchocerciasis, strongyloidiasis, scabies and …

Background Treatment of onchocerciasis using mass ivermectin administration has reduced
morbidity and transmission throughout Africa and Central/South America. Mass drug …

With the advent of multiple visual prosthesis devices to treat blindness, the question of how
potential patients view such interventions becomes important in order to understand the …

Background Control of onchocerciasis as a public health problem in Africa relies on annual
mass ivermectin distribution. New tools are needed to achieve elimination of infection. This …

Background: Onchocerciasis (river blindness), caused by the filarial worm species
Onchocerca volvulus, is a serious vector-borne neglected tropical disease (NTD) of public …

Onchocerciasis is a parasitic, vector borne disease caused by the filarial nematode
Onchocerca volvulus. More than 99% of the population at risk of infection live in Africa …